Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1625048973;48974;48975 chr2:178614859;178614858;178614857chr2:179479586;179479585;179479584
N2AB1460944050;44051;44052 chr2:178614859;178614858;178614857chr2:179479586;179479585;179479584
N2A1368241269;41270;41271 chr2:178614859;178614858;178614857chr2:179479586;179479585;179479584
N2B718521778;21779;21780 chr2:178614859;178614858;178614857chr2:179479586;179479585;179479584
Novex-1731022153;22154;22155 chr2:178614859;178614858;178614857chr2:179479586;179479585;179479584
Novex-2737722354;22355;22356 chr2:178614859;178614858;178614857chr2:179479586;179479585;179479584
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTG
  • RefSeq wild type template codon: CAC
  • Domain: Fn3-5
  • Domain position: 96
  • Structural Position: 131
  • Q(SASA): 0.4087
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/M rs1051281754 None 0.004 N 0.366 0.064 0.278968121808 gnomAD-2.1.1 5.38E-06 None None None None N None 0 0 None 0 0 None 0 None 0 1.29E-05 0
V/M rs1051281754 None 0.004 N 0.366 0.064 0.278968121808 gnomAD-4.0.0 3.40664E-06 None None None None N None 0 0 None 0 0 None 0 0 6.10575E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.1944 likely_benign 0.2325 benign -1.155 Destabilizing 0.012 N 0.281 neutral N 0.493264297 None None N
V/C 0.6791 likely_pathogenic 0.7645 pathogenic -1.155 Destabilizing 0.869 D 0.32 neutral None None None None N
V/D 0.6132 likely_pathogenic 0.703 pathogenic -1.549 Destabilizing 0.221 N 0.657 prob.neutral None None None None N
V/E 0.3601 ambiguous 0.4137 ambiguous -1.619 Destabilizing 0.177 N 0.557 neutral N 0.480254007 None None N
V/F 0.2547 likely_benign 0.2987 benign -1.361 Destabilizing 0.221 N 0.44 neutral None None None None N
V/G 0.3386 likely_benign 0.3823 ambiguous -1.346 Destabilizing 0.177 N 0.584 neutral N 0.477985068 None None N
V/H 0.614 likely_pathogenic 0.7022 pathogenic -0.809 Destabilizing 0.869 D 0.541 neutral None None None None N
V/I 0.0736 likely_benign 0.0828 benign -0.757 Destabilizing None N 0.181 neutral None None None None N
V/K 0.2836 likely_benign 0.3268 benign -0.826 Destabilizing 0.221 N 0.511 neutral None None None None N
V/L 0.2086 likely_benign 0.2607 benign -0.757 Destabilizing None N 0.159 neutral N 0.471325082 None None N
V/M 0.139 likely_benign 0.1623 benign -0.588 Destabilizing 0.004 N 0.366 neutral N 0.491259173 None None N
V/N 0.3613 ambiguous 0.4812 ambiguous -0.73 Destabilizing 0.221 N 0.602 neutral None None None None N
V/P 0.9374 likely_pathogenic 0.956 pathogenic -0.857 Destabilizing 0.366 N 0.609 neutral None None None None N
V/Q 0.3052 likely_benign 0.3587 ambiguous -1.079 Destabilizing 0.366 N 0.526 neutral None None None None N
V/R 0.2856 likely_benign 0.3299 benign -0.241 Destabilizing 0.221 N 0.6 neutral None None None None N
V/S 0.2682 likely_benign 0.3401 ambiguous -1.126 Destabilizing 0.039 N 0.465 neutral None None None None N
V/T 0.1423 likely_benign 0.1706 benign -1.104 Destabilizing 0.003 N 0.193 neutral None None None None N
V/W 0.8735 likely_pathogenic 0.9016 pathogenic -1.422 Destabilizing 0.869 D 0.646 neutral None None None None N
V/Y 0.67 likely_pathogenic 0.7553 pathogenic -1.079 Destabilizing 0.366 N 0.358 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.